Caribou Biosciences, Inc. (CRBU)
$1.65-$0.01 (-0.60%) Today
Latest CRBU Insider Trades
Timothy P. Kelly - OfficerOpen-market sale$12K
Timothy P. Kelly - OfficerTimothy P. Kelly - Officer
Tina M. Albertson - OfficerTimothy P. Kelly - OfficerTimothy P. Kelly - OfficerCaribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
No Form 4 activity for CRBU in the last 90 days.
15 Form 4 filings on record, the earliest from Nov 22, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Timothy P. Kelly - Officer | Open-market sale | Common Stock | 6,228 | $1.93 | $12K | |
| Timothy P. Kelly - Officer | Grant or award | Common Stock | 45,000 | $0.00 | - | |
| Timothy P. Kelly - Officer | Open-market sale | Common Stock | 3,147 | $1.96 | $6K | |
| Timothy P. Kelly - Officer | Grant or award | Option to purchase Common Stock | 202,500 | $0.00 | - | |
| Barbara G. McClung - Officer | Grant or award | Common Stock | 45,000 | $0.00 | - | |
| Barbara G. McClung - Officer | Open-market sale | Common Stock | 6,938 | $1.96 | $14K | |
| Barbara G. McClung - Officer | Grant or award | Option to purchase Common Stock | 202,500 | $0.00 | - | |
| Ruhi Ahmad Khan - Officer | Grant or award | Common Stock | 45,000 | $0.00 | - | |
| Ruhi Ahmad Khan - Officer | Open-market sale | Common Stock | 6,938 | $1.96 | $14K | |
| Ruhi Ahmad Khan - Officer | Grant or award | Option to purchase Common Stock | 202,500 | $0.00 | - | |
| Tina M. Albertson - Officer | Grant or award | Common Stock | 55,000 | $0.00 | - | |
| Tina M. Albertson - Officer | Open-market sale | Common Stock | 1,066 | $1.96 | $2K | |
| Tina M. Albertson - Officer | Grant or award | Option to purchase Common Stock | 247,500 | $0.00 | - | |
| Ran Zheng - Director | Grant or award | Option to purchase Common Stock | 45,000 | $0.00 | - | |
| Nancy Whiting - Director | Grant or award | Option to purchase Common Stock | 45,000 | $0.00 | - | |
| Natalie Sacks - Director | Grant or award | Option to purchase Common Stock | 45,000 | $0.00 | - | |
| Dara Richardson-Heron - Director | Grant or award | Option to purchase Common Stock | 45,000 | $0.00 | - | |
| David Lee Johnson - Director | Grant or award | Option to purchase Common Stock | 45,000 | $0.00 | - | |
 Andrew Guggenhime - Director | Grant or award | Option to purchase Common Stock | 45,000 | $0.00 | - | |
| Scott Braunstein - Director | Grant or award | Option to purchase Common Stock | 45,000 | $0.00 | - | |
 Sriram Ryali - Officer | Grant or award | Common Stock | 55,000 | $0.00 | - | |
| Sriram Ryali - Officer | Grant or award | Option to purchase Common Stock | 247,500 | $0.00 | - | |
| Rachel E. Haurwitz - Officer | Grant or award | Common Stock | 151,700 | $0.00 | - | |
| Rachel E. Haurwitz - Officer | Grant or award | Option to purchase Common Stock | 682,500 | $0.00 | - | |
| Ryan Fischesser - Officer | Grant or award | Common Stock | 25,000 | $0.00 | - |
Caribou Biosciences, Inc. (CRBU) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-02-27. The full record for CRBU runs to 15 Form 4 filings, the earliest from 2024-11-22. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CRBU were filed in the last 90 days.
No insider sales of CRBU were filed in the last 90 days. 5 sales are on record for this company.
This page tracks CRBU Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CRBU to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
